Edward Dul

3.0k total citations · 1 hit paper
8 papers, 1.7k citations indexed

About

Edward Dul is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Edward Dul has authored 8 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Rheumatology. Recurrent topics in Edward Dul's work include Bone and Dental Protein Studies (2 papers), Bone Metabolism and Diseases (2 papers) and Dental materials and restorations (1 paper). Edward Dul is often cited by papers focused on Bone and Dental Protein Studies (2 papers), Bone Metabolism and Diseases (2 papers) and Dental materials and restorations (1 paper). Edward Dul collaborates with scholars based in United States, United Kingdom and France. Edward Dul's co-authors include Edward R. Appelbaum, Ian E. James, Robert A. Dodds, Keith C. Deen, Martin Rosenberg, Sally D. Lyn, Carol Silverman, Peter McDonnell, John C. Lee and Peter R. Young and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Edward Dul

8 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL

1998 989 citations John G. Emery, Peter McDonnell et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Edward Dul

Since Specialization

Citations

This map shows the geographic impact of Edward Dul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Dul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Dul more than expected).

Fields of papers citing papers by Edward Dul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Dul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Dul. The network helps show where Edward Dul may publish in the future.

Co-authorship network of co-authors of Edward Dul

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Dul. A scholar is included among the top collaborators of Edward Dul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Dul. Edward Dul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation 2014 ·Molecular Cancer Therapeutics ·Heidi M. Ott, Alan P. Graves, Melissa B. Pappalardi, Michael J. Huddleston, Wendy S. Halsey, Ashley M. Hughes, Arthur Groy, Edward Dul, Yong Jiang, Yuchen Bai, Roland S. Annan, Sharad K. Verma, Steven D. Knight, Ryan G. Kruger, Dashyant Dhanak, Benjamin Schwartz, Peter J. Tummino, Caretha L. Creasy, Michael T. McCabe	35
2	Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases 2008 ·Journal of Medicinal Chemistry ·Clark A. Sehon, (unknown), Andrew Q. Viet, Krista Goodman, Sarah E. Dowdell, P.A. Elkins, Simon F. Semus, Christopher A. Evans, Larry J. Jolivette, Robert B. Kirkpatrick, Edward Dul, Sanjay S. Khandekar, Tracey Yi, Lois L. Wright, Gary K. Smith, David J. Behm, Ross Bentley, Christopher Doe, Erding Hu, Dennis Lee	63
3	Radioligand Binding and Functional Characterization of Recombinant Human NmU1 and NmU2 Receptors Stably Expressed in Clonal Human Embryonic Kidney-293 Cells 2004 ·Pharmacology ·Nambi Aiyar, Jyoti Disa, James J. Foley, Peter T. Buckley, William E. Wixted, Mark Pullen, Usman Shabon, Edward Dul, Philip Szekeres, Nabil A. Elshourbagy, Henry M. Sarau, Edward R. Appelbaum, (unknown)	16
4	Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Erding Hu, Edward Dul, Chiu-Mei Sung, Zunxuan Chen, Robert B. Kirkpatrick, Guifeng Zhang, Kyung Johanson, Ronggang Liu, (unknown), Glenn A. Hofmann, Ricardo Macarrón, (unknown), Paloma Pérez, John A. Krawiec, James D. Winkler, Michael Jaye	300
5	Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL breakdown → 1998 ·Journal of Biological Chemistry ·John G. Emery, Peter McDonnell, (unknown), Keith C. Deen, Sally D. Lyn, Carol Silverman, Edward Dul, Edward R. Appelbaum, (unknown), (unknown), Robert A. Dodds, Ian E. James, Martin Rosenberg, John C. Lee, Peter R. Young	989
6	Improved Immunohistochemical Staining of Osteopontin (OPN) in Paraffin-Embedded Archival Bone Specimens Following Antigen Retrieval: Anti-Human OPN Antibody Recognizes Multiple Molecular Forms 1997 ·Calcified Tissue International ·Robert E. Devoll, Gerald J. Pinero, Edward R. Appelbaum, Edward Dul, Patricia Troncoso, William T. Butler, Mary C. Farach‐Carson	14
7	Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils 1997 ·Journal of Leukocyte Biology ·John R. White, (unknown), Edward Dul, Edward R. Appelbaum, Kevin O’Donnell, Daniel J. O’Shannessy, Mary Brawner, (unknown), John E. Adamou, Nabil A. Elshourbagy, Kate M. Kaiser, James J. Foley, Dulcie B. Schmidt, Kyung Johanson, Colin H. Macphee, Kitty Moores, Dean E. McNulty, Gilbert Scott, Robert P. Schleimer, Henry M. Sarau	135
8	Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: An in vitro and ex vivo study of remodeling bone 1995 ·Journal of Bone and Mineral Research ·Robert A. Dodds, Janice R. Connor, Ian E. James, (unknown), Edward R. Appelbaum, Edward Dul, Maxine Gowen	142

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact